<DOC>
	<DOCNO>NCT01207934</DOCNO>
	<brief_summary>Leptin therapy improve insulin sensitivity people leptin-deficiency known whether improves insulin action person leptin deficient . The purpose present study determine whether leptin therapy effect insulin action obese subject type 2 diabetes mellitus ( T2DM ) . A randomized , placebo control trial conduct obese subject newly-diagnosed T2DM . Subjects randomized treatment placebo , low-dose , high-dose leptin . Insulin sensitivity measure .</brief_summary>
	<brief_title>Recombinant Human Leptin Therapy Effects Insulin Action</brief_title>
	<detailed_description>Leptin therapy improve insulin sensitivity people leptin-deficiency known whether improves insulin action person leptin deficient . The purpose present study determine whether leptin therapy weight loss-independent effect insulin action obese subject type 2 diabetes mellitus ( T2DM ) . A randomized , placebo control trial conduct obese subject newly-diagnosed T2DM . Subjects randomized treatment placebo ( saline ) , low-dose ( 30 mg/d ) , high-dose ( 80 mg/d ) recombinant methionyl human ( r-met hu ) leptin 14 day . Multi-organ insulin sensitivity treatment evaluate use hyperinsulinemic-euglycemic clamp procedure conjunction stable isotopically labelled tracer infusion measure glucose , glycerol fatty acid kinetics .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>diagnose type 2 diabetes less ten year Body mass index 25 40 hemoglobin A1C 7.5 % 12.0 % fast blood glucose 90 240mg/dL smoking pregnancy diabetes medication regular exercise ( 3 hour per week ) uncontrolled hypertension : systolic blood pressure great 160 diastolic blood pressure great 95</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>diabetes</keyword>
	<keyword>obesity</keyword>
</DOC>